Maximize Your Impact at Optimizing Bioassays for Biologics 2025
Optimizing Bioassays for Biologics 2025 is scheduled for October 9 at the Hilton Alexandria Old Town in Alexandria, Virginia. This event serves as a key meeting point for professionals working across assay development, biologics manufacturing, and regulatory strategy. It convenes decision-makers from pharmaceutical and biotech organizations, CROs, and analytical development teams who influence budgets, approve platforms, and set priorities for therapeutic efficacy and comparability studies.
The event attracts senior scientists, principal investigators, directors of analytical operations, and regulatory leads focused on bioassay optimization. Attendees come ready to evaluate solutions that improve assay sensitivity, reduce variability, and comply with evolving FDA and EMA expectations. Your ability to identify these stakeholders early through Vendelux’s enriched attendee list gives you a strategic advantage in driving demand generation, building in-roads for pilot collaborations, and aligning sales conversations with current project pipelines.
Engaging prospects ahead of time—before they are booked with competing suppliers—makes it easier to secure meaningful conversations onsite and build longer-term partnerships grounded in scientific and business alignment.
How Sales, Marketing and Revops Teams Can Use This Attendee List
The enriched attendee data from Vendelux allows GTM teams to identify and prioritize conference attendees based on their functional role, scientific focus, and organizational responsibilities. Revenue-focused teams can filter for directors of bioassay development, quality control leads, or counterparts responsible for CMC filings, making it easier to target accounts at various stages of clinical and commercial pipeline development.
With access to verified titles and contact information, sellers can book meetings ahead of Alexandria by initiating discussions around assay qualification, method validation support, or platform integration tailored to their current drug program stage. Marketing teams can use this same data for segmentation, shaping messaging around regulatory compliance, throughput innovation, or multi-site consistency—key issues that the audience actively manages.
Post-event, the attendee list supports follow-ups tied directly to earlier discussions, allowing teams to convert short-term engagement into project initiation or trial program interest. This enriched conference attendee list unlocks how to get more meetings by helping sellers meet the right people with the right context.
Timing Is Everything
Optimizing Bioassays for Biologics 2025 takes place on October 9, 2025. With just five months remaining, now is the time to begin outbound outreach and agenda planning. Early engagement ensures you’re contacting decision-makers before their calendars fill with add-on sessions, scientific presentations, and peer meetings.
Vendelux gives your team a head start by helping you align outreach with confirmed and expected attendees. Use this lead time to book discovery calls, send targeted content, and confirm interest in meeting at the Hilton Alexandria Old Town. These touchpoints build familiarity and improve on-site meeting conversion rates.
What’s Included in the Optimizing Bioassays for Biologics 2025 Attendee List?
Vendelux provides visibility into senior-level professionals expected to attend using a blend of organizer data and predictive insights. Clients can upload a list of target accounts to identify existing or potential matches in the audience.
The enriched list includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email addresses, and phone numbers when available.
Where Is Optimizing Bioassays for Biologics 2025?
The event will be held at Hilton Alexandria Old Town in Alexandria, Virginia, United States.
When Is Optimizing Bioassays for Biologics 2025?
Optimizing Bioassays for Biologics 2025 takes place on October 9, 2025.
What Type of Event Is Optimizing Bioassays for Biologics 2025?
This is a scientific and technical conference focused on bioassay strategy for biologics. It brings together researchers, developers, and QA/QC professionals to exchange insights through panel discussions, keynote sessions, and networking opportunities centered around optimizing potency assays, developing fit-for-purpose methods, and applying statistical approaches to regulatory requirements.
How Many People Attend Optimizing Bioassays for Biologics 2025?
The event is expected to draw 100 to 150 attendees from across the United States and global industry hubs. The audience primarily consists of scientific directors, principal scientists, analytical leads, and regulatory-focused executives working on assay development, validation, and regulatory filing within biologics programs.
